托珠单抗 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "托珠单抗" in Chinese language version.

refsWebsite

Global rank Chinese rank

39web.archive.org

1^st place

18nih.gov

4^th place

5^th place

15doi.org

2^nd place

23^rd place

11worldcat.org

5^th place

12^th place

3bbc.co.uk

8^th place

32^nd place

2krankenpflege-journal.com

low place

2fda.gov

447^th place

581^st place

2gene.com

low place

2roche.com

low place

2jamanetwork.com

2,650^th place

1,976^th place

2elsevier.com

610^th place

388^th place

2pharmac.health.nz

low place

2clinicaltrials.gov

5,225^th place

4,888^th place

2reuters.com

49^th place

81^st place

1europa.eu

68^th place

209^th place

1confex.com

6,094^th place

4,939^th place

1acrabstracts.org

low place

1tandfonline.com

507^th place

610^th place

1drugs.com

399^th place

208^th place

1bmj.com

1,226^th place

890^th place

1archive.today

14^th place

18^th place

1adisonline.com

low place

1wsj.com

79^th place

143^rd place

1tga.gov.au

3,984^th place

1,603^rd place

1nps.org.au

low place

1gazette.govt.nz

low place

1pharmatimes.com

low place

1ilfattoquotidiano.it

823^rd place

low place

1ansa.it

493^rd place

6,827^th place

1ilmessaggero.it

1,738^th place

low place

1swissinfo.ch

1,485^th place

1,674^th place

1yale.edu

565^th place

664^th place

1nejm.org

2,374^th place

1,457^th place

1theguardian.com

12^th place

60^th place

1imperial.nhs.uk

low place

1nice.org.uk

3,258^th place

2,433^rd place

acrabstracts.org

Chaitow, J; De Benedetti, F; Brunner, H; et al. Tocilizumab in Patients With Systemic Juvenile Idiopathic Arthritis: Efficacy Data From the Placebo-Controlled 12-Week Part of the Phase 3 TENDER Trial (PDF). Arthritis & Rheumatism. 2010, 62 (Supplement 10): 1434 [2021-02-25]. （原始内容存档 (PDF)于2019-12-31）.

adisonline.com

Oldfield V, Dhillon S, Plosker GL. Tocilizumab: a review of its use in the management of rheumatoid arthritis. Drugs. 2009, 69 (5): 609–32 [2021-02-25]. PMID 19368420. doi:10.2165/00003495-200969050-00007. （原始内容存档于2013-01-16）.

ansa.it

3 patients get better on arthritis drug - English. ANSA.it. March 13, 2020 [2021-02-25]. （原始内容存档于2020-03-19）.

archive.today

Oldfield V, Dhillon S, Plosker GL. Tocilizumab: a review of its use in the management of rheumatoid arthritis. Drugs. 2009, 69 (5): 609–32 [2021-02-25]. PMID 19368420. doi:10.2165/00003495-200969050-00007. （原始内容存档于2013-01-16）.

bbc.co.uk

Tocilizumab: Arthritis drug may treat severe Covid. BBC News. 2020-11-19 [2020-11-19]. （原始内容存档于2021-01-27）（英国英语）.
Roberts, Michelle. Two more life-saving Covid drugs discovered. BBC News. 2021-01-07 [2021-01-07]. （原始内容存档于2021-01-28）（英国英语）.

news.bbc.co.uk

Jab hope for rheumatoid arthritis. October 27, 2008 [2021-02-25]. （原始内容存档于2021-01-26） –通过news.bbc.co.uk.

bmj.com

ard.bmj.com

Jones, G; Sebba, A; Gu, J; Lowenstein, M B; Calvo, A; Gomez-Reino, J J; Siri, D A; Tomšič, M; Alecock, E. Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study. Annals of the Rheumatic Diseases. 2010-01, 69 (01): 88–96. ISSN 0003-4967. PMC 3747519 . PMID 19297346. doi:10.1136/ard.2008.105197 （英语）.

clinicaltrials.gov

Clinical trial number NCT03644667 for "Tocilizumab in Cardiac Transplantation" at ClinicalTrials.gov
Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019. National Library of Medicine. March 17, 2020 [2021-02-25]. （原始内容存档于2021-02-25）.

confex.com

acr.confex.com

Roy Fleischmann; et al. LITHE: Tocilizumab Inhibits Radiographic Progression and Improves Physical Function in Rheumatoid Arthritis (RA) Patients (Pts) at 2 Yrs with Increasing Clinical Efficacy Over Time. ACR. 2009 [2021-02-25]. （原始内容存档于2020-08-09）.

doi.org

dx.doi.org

Matsuyama, Masashi; Suzuki, Takeshi; Tsuboi, Hiroto; Ito, Satoshi; Mamura, Mizuko; Goto, Daisuke; Matsumoto, Isao; Tsutsumi, Akito; Sumida, Takayuki. Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease. Internal Medicine (Tokyo, Japan). 2007, 46 (11): 771–774 [2021-05-09]. ISSN 1349-7235. PMID 17541233. doi:10.2169/internalmedicine.46.6262. （原始内容存档于2021-02-28）.
Komai, Toshihiko; Shoda, Hirofumi; Yamaguchi, Kenichi; Sakurai, Keiichi; Shibuya, Mihoko; Kubo, Kanae; Takahashi, Toshiyuki; Fujio, Keishi; Yamamoto, Kazuhiko. Neuromyelitis optica spectrum disorder complicated with Sjogren syndrome successfully treated with tocilizumab: A case report. Modern Rheumatology. 2016, 26 (2): 294–296 [2021-05-09]. ISSN 1439-7609. PMID 24313919. doi:10.3109/14397595.2013.861333. （原始内容存档于2021-05-12）.
Kieseier, Bernd C.; Stüve, Olaf; Dehmel, Thomas; Goebels, Norbert; Leussink, Verena I.; Mausberg, Anne K.; Ringelstein, Marius; Turowski, Bernd; Aktas, Orhan. Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica: Implication for Cellular Immune Responses. JAMA Neurology. 2013-03-01, 70 (3): 390. ISSN 2168-6149. doi:10.1001/jamaneurol.2013.668 （英语）.
Ayzenberg, Ilya; Kleiter, Ingo; Schröder, Alexandra; Hellwig, Kerstin; Chan, Andrew; Yamamura, Takashi; Gold, Ralf. Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy. JAMA Neurology. 2013-03-01, 70 (3): 394. ISSN 2168-6149. doi:10.1001/jamaneurol.2013.1246 （英语）.
Araki, Manabu; Aranami, Toshimasa; Matsuoka, Takako; Nakamura, Masakazu; Miyake, Sachiko; Yamamura, Takashi. Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab. Modern Rheumatology. 2013-07, 23 (4): 827–831. ISSN 1439-7595. PMC 3713263 . PMID 22782533. doi:10.3109/s10165-012-0715-9 （英语）.
Shoenfeld Y. Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning. Autoimmunity Reviews. June 2020, 19 (6): 102538 [2021-02-25]. PMC 7131471 . PMID 32268212. doi:10.1016/j.autrev.2020.102538. （原始内容存档于2020-07-23）.
Genovese, Mark C.; McKay, James D.; Nasonov, Evgeny L.; Mysler, Eduardo F.; da Silva, Nilzio A.; Alecock, Emma; Woodworth, Thasia; Gomez-Reino, Juan J. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study. Arthritis and Rheumatism. 2008-10, 58 (10): 2968–2980 [2021-05-09]. ISSN 0004-3591. PMID 18821691. doi:10.1002/art.23940. （原始内容存档于2021-09-02）.
Jones, G; Sebba, A; Gu, J; Lowenstein, M B; Calvo, A; Gomez-Reino, J J; Siri, D A; Tomšič, M; Alecock, E. Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study. Annals of the Rheumatic Diseases. 2010-01, 69 (01): 88–96. ISSN 0003-4967. PMC 3747519 . PMID 19297346. doi:10.1136/ard.2008.105197 （英语）.
Kallen, Karl-Josef. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochimica Et Biophysica Acta. 2002-11-11, 1592 (3): 323–343 [2021-05-09]. ISSN 0006-3002. PMID 12421676. doi:10.1016/s0167-4889(02)00325-7. （原始内容存档于2021-02-09）.
Oldfield V, Dhillon S, Plosker GL. Tocilizumab: a review of its use in the management of rheumatoid arthritis. Drugs. 2009, 69 (5): 609–32 [2021-02-25]. PMID 19368420. doi:10.2165/00003495-200969050-00007. （原始内容存档于2013-01-16）.
Coward J, Kulbe H, Chakravarty P, Leader D, Vassileva V, Leinster DA, et al. Interleukin-6 as a therapeutic target in human ovarian cancer. Clinical Cancer Research. September 2011, 17 (18): 6083–96. PMC 3182554 . PMID 21795409. doi:10.1158/1078-0432.CCR-11-0945.
Milagre CS, Gopinathan G, Everitt G, Thompson RG, Kulbe H, Zhong H, et al. Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer. Cancer Research. April 2015, 75 (7): 1255–64. PMC 4384986 . PMID 25670170. doi:10.1158/0008-5472.CAN-14-1801.
Hundt, Melanie A.; Deng, Yanhong; Ciarleglio, Maria M.; Nathanson, Michael H.; Lim, Joseph K. Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network. Hepatology (Baltimore, Md.). 2020-10, 72 (4): 1169–1176 [2021-05-09]. ISSN 1527-3350. PMID 32725890. doi:10.1002/hep.31487. （原始内容存档于2021-08-11）.
Alijotas-Reig, Jaume; Esteve-Valverde, Enrique; Belizna, Cristina; Selva-O'Callaghan, Albert; Pardos-Gea, Josep; Quintana, Angela; Mekinian, Arsene; Anunciacion-Llunell, Ariadna; Miró-Mur, Francesc. Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review. Autoimmunity Reviews. 2020-07, 19 (7): 102569 [2021-02-25]. PMC 7252146 . PMID 32376394. doi:10.1016/j.autrev.2020.102569. （原始内容存档于2020-10-15）（英语）.
Stone, John H.; Frigault, Matthew J.; Serling-Boyd, Naomi J.; Fernandes, Ana D.; Harvey, Liam; Foulkes, Andrea S.; Horick, Nora K.; Healy, Brian C.; Shah, Ruta. Efficacy of Tocilizumab in Patients Hospitalized with Covid-19. New England Journal of Medicine. 2020-12-10, 383 (24): 2333–2344 [2021-05-09]. ISSN 0028-4793. PMC 7646626 . PMID 33085857. doi:10.1056/NEJMoa2028836. （原始内容存档于2021-08-29）（英语）.

drugs.com

FDA Approves Actemra (tocilizumab) Subcutaneous Injection for Giant Cell Arteritis. Drugs.com. [2021-02-25]. （原始内容存档于2020-08-09）.

elsevier.com

linkinghub.elsevier.com

Shoenfeld Y. Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning. Autoimmunity Reviews. June 2020, 19 (6): 102538 [2021-02-25]. PMC 7131471 . PMID 32268212. doi:10.1016/j.autrev.2020.102538. （原始内容存档于2020-07-23）.
Alijotas-Reig, Jaume; Esteve-Valverde, Enrique; Belizna, Cristina; Selva-O'Callaghan, Albert; Pardos-Gea, Josep; Quintana, Angela; Mekinian, Arsene; Anunciacion-Llunell, Ariadna; Miró-Mur, Francesc. Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review. Autoimmunity Reviews. 2020-07, 19 (7): 102569 [2021-02-25]. PMC 7252146 . PMID 32376394. doi:10.1016/j.autrev.2020.102569. （原始内容存档于2020-10-15）（英语）.

europa.eu

ema.europa.eu

Assessment report for RoActemra (PDF). European Medicines Agency. [2021-02-25]. （原始内容存档 (PDF)于2016-01-19）.

fda.gov

Tocilizumab Emergency Use Authorization (EUA) (PDF). U.S. Food and Drug Administration (FDA). June 2021 [31 July 2021]. （原始内容存档于25 November 2021）.
FDA approves tisagenlecleucel for B-cell ALL and tocilizumab for cytokine release syndrome. US FDA. 30 August 2017 [2021-02-25]. （原始内容存档于2021-08-29）.

gazette.govt.nz

Richards, Mark. Consent to the Distribution of New Medicines. New Zealand Gazette. 20 July 2009, 2009 (105): 2418 [9 June 2015]. （原始内容存档于2020-08-09）.

gene.com

Genentech Gains FDA Approval for New Subcutaneous Formulation of Actemra for use in Adult Patients Living with Moderately to Severely Active Rheumatoid Arthritis. Genentech. 21 October 2013. （原始内容存档于8 September 2017）.
FDA Approves ACTEMRA® (tocilizumab) for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA), South San Francisco, California: Genentech, April 15, 2011 [July 20, 2015], （原始内容存档于1 October 2018）

ilfattoquotidiano.it

Coronavirus, farmaco per curare l'artrite reumatoide efficace su due pazienti con polmonite severa da Covid 19 [Coronavirus, drug to treat rheumatoid arthritis effective on two patients with severe pneumonia from Covid 19]. Il fatto quotidiano. 2020-03-09 [2021-02-25]. （原始内容存档于2020-08-09）（意大利语）.

ilmessaggero.it

Coronavirus, via libera dell'Aifa al farmaco anti-artrite efficace su 3 pazienti e a un antivirale: test in 5 centri. www.ilmessaggero.it. [2020-03-14]. （原始内容存档于2020-03-19）（意大利语）.

imperial.nhs.uk

Initial data shows arthritis drug is effective in treating sickest Covid-19 patients. www.imperial.nhs.uk. [2020-11-19]. （原始内容存档于2020-11-29）（英语）.

jamanetwork.com

archneur.jamanetwork.com

Kieseier, Bernd C.; Stüve, Olaf; Dehmel, Thomas; Goebels, Norbert; Leussink, Verena I.; Mausberg, Anne K.; Ringelstein, Marius; Turowski, Bernd; Aktas, Orhan. Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica: Implication for Cellular Immune Responses. JAMA Neurology. 2013-03-01, 70 (3): 390. ISSN 2168-6149. doi:10.1001/jamaneurol.2013.668 （英语）.
Ayzenberg, Ilya; Kleiter, Ingo; Schröder, Alexandra; Hellwig, Kerstin; Chan, Andrew; Yamamura, Takashi; Gold, Ralf. Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy. JAMA Neurology. 2013-03-01, 70 (3): 394. ISSN 2168-6149. doi:10.1001/jamaneurol.2013.1246 （英语）.

krankenpflege-journal.com

Markus Harwart. Die Entwicklung von Tocilizumab [The development of tocilizumab]. Krankenpflege-Journal. 2008 [2016-04-30]. （原始内容存档于2018-10-15）（德语）.
Markus Harwart. Die Entwicklung von Tocilizumab [The development of tocilizumab]. Krankenpflege-Journal. 2008. （原始内容存档于15 October 2018）（德语）.

nejm.org

Stone, John H.; Frigault, Matthew J.; Serling-Boyd, Naomi J.; Fernandes, Ana D.; Harvey, Liam; Foulkes, Andrea S.; Horick, Nora K.; Healy, Brian C.; Shah, Ruta. Efficacy of Tocilizumab in Patients Hospitalized with Covid-19. New England Journal of Medicine. 2020-12-10, 383 (24): 2333–2344 [2021-05-09]. ISSN 0028-4793. PMC 7646626 . PMID 33085857. doi:10.1056/NEJMoa2028836. （原始内容存档于2021-08-29）（英语）.

nice.org.uk

"Product overview COVID-19 rapid evidence summary: Tocilizumab for COVID-19 Advice; NICE". [20 January 2020]. （原始内容存档于2021-01-18）.

nih.gov

ncbi.nlm.nih.gov

Matsuyama, Masashi; Suzuki, Takeshi; Tsuboi, Hiroto; Ito, Satoshi; Mamura, Mizuko; Goto, Daisuke; Matsumoto, Isao; Tsutsumi, Akito; Sumida, Takayuki. Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease. Internal Medicine (Tokyo, Japan). 2007, 46 (11): 771–774 [2021-05-09]. ISSN 1349-7235. PMID 17541233. doi:10.2169/internalmedicine.46.6262. （原始内容存档于2021-02-28）.
Komai, Toshihiko; Shoda, Hirofumi; Yamaguchi, Kenichi; Sakurai, Keiichi; Shibuya, Mihoko; Kubo, Kanae; Takahashi, Toshiyuki; Fujio, Keishi; Yamamoto, Kazuhiko. Neuromyelitis optica spectrum disorder complicated with Sjogren syndrome successfully treated with tocilizumab: A case report. Modern Rheumatology. 2016, 26 (2): 294–296 [2021-05-09]. ISSN 1439-7609. PMID 24313919. doi:10.3109/14397595.2013.861333. （原始内容存档于2021-05-12）.
Araki, Manabu; Aranami, Toshimasa; Matsuoka, Takako; Nakamura, Masakazu; Miyake, Sachiko; Yamamura, Takashi. Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab. Modern Rheumatology. 2013-07, 23 (4): 827–831. ISSN 1439-7595. PMC 3713263 . PMID 22782533. doi:10.3109/s10165-012-0715-9 （英语）.
Shoenfeld Y. Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning. Autoimmunity Reviews. June 2020, 19 (6): 102538 [2021-02-25]. PMC 7131471 . PMID 32268212. doi:10.1016/j.autrev.2020.102538. （原始内容存档于2020-07-23）.
Genovese, Mark C.; McKay, James D.; Nasonov, Evgeny L.; Mysler, Eduardo F.; da Silva, Nilzio A.; Alecock, Emma; Woodworth, Thasia; Gomez-Reino, Juan J. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study. Arthritis and Rheumatism. 2008-10, 58 (10): 2968–2980 [2021-05-09]. ISSN 0004-3591. PMID 18821691. doi:10.1002/art.23940. （原始内容存档于2021-09-02）.
Jones, G; Sebba, A; Gu, J; Lowenstein, M B; Calvo, A; Gomez-Reino, J J; Siri, D A; Tomšič, M; Alecock, E. Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study. Annals of the Rheumatic Diseases. 2010-01, 69 (01): 88–96. ISSN 0003-4967. PMC 3747519 . PMID 19297346. doi:10.1136/ard.2008.105197 （英语）.
Kallen, Karl-Josef. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochimica Et Biophysica Acta. 2002-11-11, 1592 (3): 323–343 [2021-05-09]. ISSN 0006-3002. PMID 12421676. doi:10.1016/s0167-4889(02)00325-7. （原始内容存档于2021-02-09）.
Oldfield V, Dhillon S, Plosker GL. Tocilizumab: a review of its use in the management of rheumatoid arthritis. Drugs. 2009, 69 (5): 609–32 [2021-02-25]. PMID 19368420. doi:10.2165/00003495-200969050-00007. （原始内容存档于2013-01-16）.
Coward J, Kulbe H, Chakravarty P, Leader D, Vassileva V, Leinster DA, et al. Interleukin-6 as a therapeutic target in human ovarian cancer. Clinical Cancer Research. September 2011, 17 (18): 6083–96. PMC 3182554 . PMID 21795409. doi:10.1158/1078-0432.CCR-11-0945.
Milagre CS, Gopinathan G, Everitt G, Thompson RG, Kulbe H, Zhong H, et al. Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer. Cancer Research. April 2015, 75 (7): 1255–64. PMC 4384986 . PMID 25670170. doi:10.1158/0008-5472.CAN-14-1801.
Hundt, Melanie A.; Deng, Yanhong; Ciarleglio, Maria M.; Nathanson, Michael H.; Lim, Joseph K. Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network. Hepatology (Baltimore, Md.). 2020-10, 72 (4): 1169–1176 [2021-05-09]. ISSN 1527-3350. PMID 32725890. doi:10.1002/hep.31487. （原始内容存档于2021-08-11）.
Alijotas-Reig, Jaume; Esteve-Valverde, Enrique; Belizna, Cristina; Selva-O'Callaghan, Albert; Pardos-Gea, Josep; Quintana, Angela; Mekinian, Arsene; Anunciacion-Llunell, Ariadna; Miró-Mur, Francesc. Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review. Autoimmunity Reviews. 2020-07, 19 (7): 102569 [2021-02-25]. PMC 7252146 . PMID 32376394. doi:10.1016/j.autrev.2020.102569. （原始内容存档于2020-10-15）（英语）.
Stone, John H.; Frigault, Matthew J.; Serling-Boyd, Naomi J.; Fernandes, Ana D.; Harvey, Liam; Foulkes, Andrea S.; Horick, Nora K.; Healy, Brian C.; Shah, Ruta. Efficacy of Tocilizumab in Patients Hospitalized with Covid-19. New England Journal of Medicine. 2020-12-10, 383 (24): 2333–2344 [2021-05-09]. ISSN 0028-4793. PMC 7646626 . PMID 33085857. doi:10.1056/NEJMoa2028836. （原始内容存档于2021-08-29）（英语）.

pubmed.ncbi.nlm.nih.gov

Matsuyama, Masashi; Suzuki, Takeshi; Tsuboi, Hiroto; Ito, Satoshi; Mamura, Mizuko; Goto, Daisuke; Matsumoto, Isao; Tsutsumi, Akito; Sumida, Takayuki. Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease. Internal Medicine (Tokyo, Japan). 2007, 46 (11): 771–774 [2021-05-09]. ISSN 1349-7235. PMID 17541233. doi:10.2169/internalmedicine.46.6262. （原始内容存档于2021-02-28）.
Komai, Toshihiko; Shoda, Hirofumi; Yamaguchi, Kenichi; Sakurai, Keiichi; Shibuya, Mihoko; Kubo, Kanae; Takahashi, Toshiyuki; Fujio, Keishi; Yamamoto, Kazuhiko. Neuromyelitis optica spectrum disorder complicated with Sjogren syndrome successfully treated with tocilizumab: A case report. Modern Rheumatology. 2016, 26 (2): 294–296 [2021-05-09]. ISSN 1439-7609. PMID 24313919. doi:10.3109/14397595.2013.861333. （原始内容存档于2021-05-12）.
Genovese, Mark C.; McKay, James D.; Nasonov, Evgeny L.; Mysler, Eduardo F.; da Silva, Nilzio A.; Alecock, Emma; Woodworth, Thasia; Gomez-Reino, Juan J. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study. Arthritis and Rheumatism. 2008-10, 58 (10): 2968–2980 [2021-05-09]. ISSN 0004-3591. PMID 18821691. doi:10.1002/art.23940. （原始内容存档于2021-09-02）.
Kallen, Karl-Josef. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochimica Et Biophysica Acta. 2002-11-11, 1592 (3): 323–343 [2021-05-09]. ISSN 0006-3002. PMID 12421676. doi:10.1016/s0167-4889(02)00325-7. （原始内容存档于2021-02-09）.
Hundt, Melanie A.; Deng, Yanhong; Ciarleglio, Maria M.; Nathanson, Michael H.; Lim, Joseph K. Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network. Hepatology (Baltimore, Md.). 2020-10, 72 (4): 1169–1176 [2021-05-09]. ISSN 1527-3350. PMID 32725890. doi:10.1002/hep.31487. （原始内容存档于2021-08-11）.

nps.org.au

Anakinra (Kineret) to be deleted from the PBS. National Prescribing Service Limited. 1 August 2010. （原始内容存档于3 June 2012）.

pharmac.health.nz

Approval of proposal involving pegfilgrastim and tocilizumab (PDF). Pharmaceutical Management Agency. 24 May 2013 [9 June 2015].
Decision to widen access to tocilizumab (Actemra) for rheumatoid arthritis in patients who are unable to be treated with methotrexate (PDF). Pharmaceutical Management Agency. 14 May 2014 [9 June 2015].

pharmatimes.com

Roche links with UK gov for ground-breaking PAH trial. PharmaTimes Media Ltd. 2016-01-06 [2021-02-25]. （原始内容存档于2016-03-06）.

reuters.com

Miller, Roxanne Liu, John. China approves use of Roche drug in battle against coronavirus complications. Reuters. 2020-03-04 [2021-05-09]. （原始内容存档于2020-03-05）（英语）.
China approves use of Roche arthritis drug for coronavirus patients. Reuters. 2020-03-04 [2021-02-25]. （原始内容存档于2020-03-12）.

roche.com

RoActemra approved in Europe to treat patients suffering from Rheumatoid Arthritis (新闻稿). Hoffmann–La Roche. 2009-01-21 [2009-01-05]. （原始内容存档于2009-02-28）.
Roche provides an update on the phase III COVACTA trial of Actemra/RoActemra in hospitalized patients with severe COVID-19 associated pneumonia. www.roche.com. 29 July 2020 [2020-08-18]. （原始内容存档于2021-01-09）（英语）.

swissinfo.ch

WHO and Roche launch trials of potential coronavirus treatments. SwissInfo.Ch. [2021-02-25]. （原始内容存档于2020-03-21）.

tandfonline.com

Araki, Manabu; Aranami, Toshimasa; Matsuoka, Takako; Nakamura, Masakazu; Miyake, Sachiko; Yamamura, Takashi. Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab. Modern Rheumatology. 2013-07, 23 (4): 827–831. ISSN 1439-7595. PMC 3713263 . PMID 22782533. doi:10.3109/s10165-012-0715-9 （英语）.

tga.gov.au

Australian Drug Evaluation Committee 263rd meeting resolutions. Therapeutic Goods Administration. 27 May 2009. （原始内容存档于20 August 2009）.

theguardian.com

Sample, Ian. Rheumatoid arthritis drug appears to help Covid patients in ICU. The Guardian. 2020-11-19 [2020-11-19]. ISSN 0261-3077. （原始内容存档于2021-02-12）（英国英语）.

web.archive.org

Markus Harwart. Die Entwicklung von Tocilizumab [The development of tocilizumab]. Krankenpflege-Journal. 2008 [2016-04-30]. （原始内容存档于2018-10-15）（德语）.
Tocilizumab Emergency Use Authorization (EUA) (PDF). U.S. Food and Drug Administration (FDA). June 2021 [31 July 2021]. （原始内容存档于25 November 2021）.
Genentech Gains FDA Approval for New Subcutaneous Formulation of Actemra for use in Adult Patients Living with Moderately to Severely Active Rheumatoid Arthritis. Genentech. 21 October 2013. （原始内容存档于8 September 2017）.
RoActemra approved in Europe to treat patients suffering from Rheumatoid Arthritis (新闻稿). Hoffmann–La Roche. 2009-01-21 [2009-01-05]. （原始内容存档于2009-02-28）.
Assessment report for RoActemra (PDF). European Medicines Agency. [2021-02-25]. （原始内容存档 (PDF)于2016-01-19）.
Roy Fleischmann; et al. LITHE: Tocilizumab Inhibits Radiographic Progression and Improves Physical Function in Rheumatoid Arthritis (RA) Patients (Pts) at 2 Yrs with Increasing Clinical Efficacy Over Time. ACR. 2009 [2021-02-25]. （原始内容存档于2020-08-09）.
Chaitow, J; De Benedetti, F; Brunner, H; et al. Tocilizumab in Patients With Systemic Juvenile Idiopathic Arthritis: Efficacy Data From the Placebo-Controlled 12-Week Part of the Phase 3 TENDER Trial (PDF). Arthritis & Rheumatism. 2010, 62 (Supplement 10): 1434 [2021-02-25]. （原始内容存档 (PDF)于2019-12-31）.
FDA Approves ACTEMRA® (tocilizumab) for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA), South San Francisco, California: Genentech, April 15, 2011 [July 20, 2015], （原始内容存档于1 October 2018）
Matsuyama, Masashi; Suzuki, Takeshi; Tsuboi, Hiroto; Ito, Satoshi; Mamura, Mizuko; Goto, Daisuke; Matsumoto, Isao; Tsutsumi, Akito; Sumida, Takayuki. Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease. Internal Medicine (Tokyo, Japan). 2007, 46 (11): 771–774 [2021-05-09]. ISSN 1349-7235. PMID 17541233. doi:10.2169/internalmedicine.46.6262. （原始内容存档于2021-02-28）.
Komai, Toshihiko; Shoda, Hirofumi; Yamaguchi, Kenichi; Sakurai, Keiichi; Shibuya, Mihoko; Kubo, Kanae; Takahashi, Toshiyuki; Fujio, Keishi; Yamamoto, Kazuhiko. Neuromyelitis optica spectrum disorder complicated with Sjogren syndrome successfully treated with tocilizumab: A case report. Modern Rheumatology. 2016, 26 (2): 294–296 [2021-05-09]. ISSN 1439-7609. PMID 24313919. doi:10.3109/14397595.2013.861333. （原始内容存档于2021-05-12）.
FDA Approves Actemra (tocilizumab) Subcutaneous Injection for Giant Cell Arteritis. Drugs.com. [2021-02-25]. （原始内容存档于2020-08-09）.
FDA approves tisagenlecleucel for B-cell ALL and tocilizumab for cytokine release syndrome. US FDA. 30 August 2017 [2021-02-25]. （原始内容存档于2021-08-29）.
Shoenfeld Y. Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning. Autoimmunity Reviews. June 2020, 19 (6): 102538 [2021-02-25]. PMC 7131471 . PMID 32268212. doi:10.1016/j.autrev.2020.102538. （原始内容存档于2020-07-23）.
Roche provides an update on the phase III COVACTA trial of Actemra/RoActemra in hospitalized patients with severe COVID-19 associated pneumonia. www.roche.com. 29 July 2020 [2020-08-18]. （原始内容存档于2021-01-09）（英语）.
Tocilizumab: Arthritis drug may treat severe Covid. BBC News. 2020-11-19 [2020-11-19]. （原始内容存档于2021-01-27）（英国英语）.
Roberts, Michelle. Two more life-saving Covid drugs discovered. BBC News. 2021-01-07 [2021-01-07]. （原始内容存档于2021-01-28）（英国英语）.
Genovese, Mark C.; McKay, James D.; Nasonov, Evgeny L.; Mysler, Eduardo F.; da Silva, Nilzio A.; Alecock, Emma; Woodworth, Thasia; Gomez-Reino, Juan J. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study. Arthritis and Rheumatism. 2008-10, 58 (10): 2968–2980 [2021-05-09]. ISSN 0004-3591. PMID 18821691. doi:10.1002/art.23940. （原始内容存档于2021-09-02）.
Kallen, Karl-Josef. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochimica Et Biophysica Acta. 2002-11-11, 1592 (3): 323–343 [2021-05-09]. ISSN 0006-3002. PMID 12421676. doi:10.1016/s0167-4889(02)00325-7. （原始内容存档于2021-02-09）.
Markus Harwart. Die Entwicklung von Tocilizumab [The development of tocilizumab]. Krankenpflege-Journal. 2008. （原始内容存档于15 October 2018）（德语）.
Jab hope for rheumatoid arthritis. October 27, 2008 [2021-02-25]. （原始内容存档于2021-01-26） –通过news.bbc.co.uk.
Roche: FDA Approves Actemra For Rheumatoid Arthritis. The Wall Street Journal. 11 January 2010. （原始内容存档于January 14, 2010）.
Australian Drug Evaluation Committee 263rd meeting resolutions. Therapeutic Goods Administration. 27 May 2009. （原始内容存档于20 August 2009）.
Anakinra (Kineret) to be deleted from the PBS. National Prescribing Service Limited. 1 August 2010. （原始内容存档于3 June 2012）.
Richards, Mark. Consent to the Distribution of New Medicines. New Zealand Gazette. 20 July 2009, 2009 (105): 2418 [9 June 2015]. （原始内容存档于2020-08-09）.
Roche links with UK gov for ground-breaking PAH trial. PharmaTimes Media Ltd. 2016-01-06 [2021-02-25]. （原始内容存档于2016-03-06）.
Miller, Roxanne Liu, John. China approves use of Roche drug in battle against coronavirus complications. Reuters. 2020-03-04 [2021-05-09]. （原始内容存档于2020-03-05）（英语）.
China approves use of Roche arthritis drug for coronavirus patients. Reuters. 2020-03-04 [2021-02-25]. （原始内容存档于2020-03-12）.
Coronavirus, farmaco per curare l'artrite reumatoide efficace su due pazienti con polmonite severa da Covid 19 [Coronavirus, drug to treat rheumatoid arthritis effective on two patients with severe pneumonia from Covid 19]. Il fatto quotidiano. 2020-03-09 [2021-02-25]. （原始内容存档于2020-08-09）（意大利语）.
Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019. National Library of Medicine. March 17, 2020 [2021-02-25]. （原始内容存档于2021-02-25）.
3 patients get better on arthritis drug - English. ANSA.it. March 13, 2020 [2021-02-25]. （原始内容存档于2020-03-19）.
Coronavirus, via libera dell'Aifa al farmaco anti-artrite efficace su 3 pazienti e a un antivirale: test in 5 centri. www.ilmessaggero.it. [2020-03-14]. （原始内容存档于2020-03-19）（意大利语）.
WHO and Roche launch trials of potential coronavirus treatments. SwissInfo.Ch. [2021-02-25]. （原始内容存档于2020-03-21）.
Hundt, Melanie A.; Deng, Yanhong; Ciarleglio, Maria M.; Nathanson, Michael H.; Lim, Joseph K. Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network. Hepatology (Baltimore, Md.). 2020-10, 72 (4): 1169–1176 [2021-05-09]. ISSN 1527-3350. PMID 32725890. doi:10.1002/hep.31487. （原始内容存档于2021-08-11）.
Belli, Brita. Strong link found between abnormal liver tests and poor COVID-19 outcomes. YaleNews. 2020-08-06 [2021-05-09]. （原始内容存档于2020-12-31）（英语）.
Alijotas-Reig, Jaume; Esteve-Valverde, Enrique; Belizna, Cristina; Selva-O'Callaghan, Albert; Pardos-Gea, Josep; Quintana, Angela; Mekinian, Arsene; Anunciacion-Llunell, Ariadna; Miró-Mur, Francesc. Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review. Autoimmunity Reviews. 2020-07, 19 (7): 102569 [2021-02-25]. PMC 7252146 . PMID 32376394. doi:10.1016/j.autrev.2020.102569. （原始内容存档于2020-10-15）（英语）.
Stone, John H.; Frigault, Matthew J.; Serling-Boyd, Naomi J.; Fernandes, Ana D.; Harvey, Liam; Foulkes, Andrea S.; Horick, Nora K.; Healy, Brian C.; Shah, Ruta. Efficacy of Tocilizumab in Patients Hospitalized with Covid-19. New England Journal of Medicine. 2020-12-10, 383 (24): 2333–2344 [2021-05-09]. ISSN 0028-4793. PMC 7646626 . PMID 33085857. doi:10.1056/NEJMoa2028836. （原始内容存档于2021-08-29）（英语）.
Sample, Ian. Rheumatoid arthritis drug appears to help Covid patients in ICU. The Guardian. 2020-11-19 [2020-11-19]. ISSN 0261-3077. （原始内容存档于2021-02-12）（英国英语）.
Initial data shows arthritis drug is effective in treating sickest Covid-19 patients. www.imperial.nhs.uk. [2020-11-19]. （原始内容存档于2020-11-29）（英语）.
"Product overview COVID-19 rapid evidence summary: Tocilizumab for COVID-19 Advice; NICE". [20 January 2020]. （原始内容存档于2021-01-18）.

worldcat.org

Matsuyama, Masashi; Suzuki, Takeshi; Tsuboi, Hiroto; Ito, Satoshi; Mamura, Mizuko; Goto, Daisuke; Matsumoto, Isao; Tsutsumi, Akito; Sumida, Takayuki. Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease. Internal Medicine (Tokyo, Japan). 2007, 46 (11): 771–774 [2021-05-09]. ISSN 1349-7235. PMID 17541233. doi:10.2169/internalmedicine.46.6262. （原始内容存档于2021-02-28）.
Komai, Toshihiko; Shoda, Hirofumi; Yamaguchi, Kenichi; Sakurai, Keiichi; Shibuya, Mihoko; Kubo, Kanae; Takahashi, Toshiyuki; Fujio, Keishi; Yamamoto, Kazuhiko. Neuromyelitis optica spectrum disorder complicated with Sjogren syndrome successfully treated with tocilizumab: A case report. Modern Rheumatology. 2016, 26 (2): 294–296 [2021-05-09]. ISSN 1439-7609. PMID 24313919. doi:10.3109/14397595.2013.861333. （原始内容存档于2021-05-12）.
Kieseier, Bernd C.; Stüve, Olaf; Dehmel, Thomas; Goebels, Norbert; Leussink, Verena I.; Mausberg, Anne K.; Ringelstein, Marius; Turowski, Bernd; Aktas, Orhan. Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica: Implication for Cellular Immune Responses. JAMA Neurology. 2013-03-01, 70 (3): 390. ISSN 2168-6149. doi:10.1001/jamaneurol.2013.668 （英语）.
Ayzenberg, Ilya; Kleiter, Ingo; Schröder, Alexandra; Hellwig, Kerstin; Chan, Andrew; Yamamura, Takashi; Gold, Ralf. Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy. JAMA Neurology. 2013-03-01, 70 (3): 394. ISSN 2168-6149. doi:10.1001/jamaneurol.2013.1246 （英语）.
Araki, Manabu; Aranami, Toshimasa; Matsuoka, Takako; Nakamura, Masakazu; Miyake, Sachiko; Yamamura, Takashi. Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab. Modern Rheumatology. 2013-07, 23 (4): 827–831. ISSN 1439-7595. PMC 3713263 . PMID 22782533. doi:10.3109/s10165-012-0715-9 （英语）.
Genovese, Mark C.; McKay, James D.; Nasonov, Evgeny L.; Mysler, Eduardo F.; da Silva, Nilzio A.; Alecock, Emma; Woodworth, Thasia; Gomez-Reino, Juan J. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study. Arthritis and Rheumatism. 2008-10, 58 (10): 2968–2980 [2021-05-09]. ISSN 0004-3591. PMID 18821691. doi:10.1002/art.23940. （原始内容存档于2021-09-02）.
Jones, G; Sebba, A; Gu, J; Lowenstein, M B; Calvo, A; Gomez-Reino, J J; Siri, D A; Tomšič, M; Alecock, E. Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study. Annals of the Rheumatic Diseases. 2010-01, 69 (01): 88–96. ISSN 0003-4967. PMC 3747519 . PMID 19297346. doi:10.1136/ard.2008.105197 （英语）.
Kallen, Karl-Josef. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochimica Et Biophysica Acta. 2002-11-11, 1592 (3): 323–343 [2021-05-09]. ISSN 0006-3002. PMID 12421676. doi:10.1016/s0167-4889(02)00325-7. （原始内容存档于2021-02-09）.
Hundt, Melanie A.; Deng, Yanhong; Ciarleglio, Maria M.; Nathanson, Michael H.; Lim, Joseph K. Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network. Hepatology (Baltimore, Md.). 2020-10, 72 (4): 1169–1176 [2021-05-09]. ISSN 1527-3350. PMID 32725890. doi:10.1002/hep.31487. （原始内容存档于2021-08-11）.
Stone, John H.; Frigault, Matthew J.; Serling-Boyd, Naomi J.; Fernandes, Ana D.; Harvey, Liam; Foulkes, Andrea S.; Horick, Nora K.; Healy, Brian C.; Shah, Ruta. Efficacy of Tocilizumab in Patients Hospitalized with Covid-19. New England Journal of Medicine. 2020-12-10, 383 (24): 2333–2344 [2021-05-09]. ISSN 0028-4793. PMC 7646626 . PMID 33085857. doi:10.1056/NEJMoa2028836. （原始内容存档于2021-08-29）（英语）.
Sample, Ian. Rheumatoid arthritis drug appears to help Covid patients in ICU. The Guardian. 2020-11-19 [2020-11-19]. ISSN 0261-3077. （原始内容存档于2021-02-12）（英国英语）.

wsj.com

online.wsj.com

Roche: FDA Approves Actemra For Rheumatoid Arthritis. The Wall Street Journal. 11 January 2010. （原始内容存档于January 14, 2010）.

yale.edu

news.yale.edu

Belli, Brita. Strong link found between abnormal liver tests and poor COVID-19 outcomes. YaleNews. 2020-08-06 [2021-05-09]. （原始内容存档于2020-12-31）（英语）.